In cancer treatment, 5 immunotherapy drugs have been included in the reimbursement coverage.

In cancer treatment, 5 immunotherapy drugs have been included in the reimbursement coverage.

10.07.2025 02:00

The Minister of Labor and Social Security, Vedat Işıkhan, announced that 5 immunotherapy drugs used against 25 different subtypes of cancer have been included in the reimbursement coverage of the Social Security Institution.

İşte mevcut HTML yapısını bozmadan metnin İngilizce çevirisi ve img tag'larındaki title ve alt tag'lerinin de tercümesi:



```html

Minister of Labor and Social Security Vedat Işıkhan announced news that closely concerns cancer patients. Minister Işıkhan stated that 5 immunotherapy drugs applied against 25 different subtypes of cancer have been included in the reimbursement scope of SGK.

5 CANCER DRUGS INCLUDED IN REIMBURSEMENT SCOPE

In a statement made on his social media account, Minister Işıkhan said: "With the good news announced by our President Mr. Recep Tayyip Erdoğan after our Presidential Cabinet Meeting, we will provide significant support to our citizens fighting against cancer. We are including 5 immunotherapy drugs applied against 25 different subtypes of cancer in the reimbursement scope of our Social Security Institution, along with the body's own immune system.

With the upcoming regulation, 48,000 cancer patients will benefit from these treatments. With this regulation, the number of cancer drugs on the reimbursement list will rise to 784. We will continue to stand by our citizens fighting against cancer in their struggles. I hope the drugs will bring healing to our patients."

5 immunotherapy drugs for cancer treatment included in the reimbursement scope
5 immunotherapy drugs for cancer treatment included in the reimbursement scope


```



Bu çeviri, metni ve img tag'larındaki title ve alt tag'lerini İngilizceye doğru bir şekilde çevirmektedir.

In order to provide you with a better service, we position cookies on our site. Your personal data is collected and processed within the scope of KVKK and GDPR. For detailed information, you can review our Data Policy / Disclosure Text. By using our site, you agree to our use of cookies.', '